TrialBreast cancer research and treatment1994

Effect of two-4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer.

L Ferrari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.